BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 24379611)

  • 1. Mitochondrial DNA alterations and mitochondrial dysfunction in the progression of hepatocellular carcinoma.
    Hsu CC; Lee HC; Wei YH
    World J Gastroenterol; 2013 Dec; 19(47):8880-6. PubMed ID: 24379611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration of the copy number and deletion of mitochondrial DNA in human hepatocellular carcinoma.
    Yin PH; Lee HC; Chau GY; Wu YT; Li SH; Lui WY; Wei YH; Liu TY; Chi CW
    Br J Cancer; 2004 Jun; 90(12):2390-6. PubMed ID: 15150555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatic alterations in mitochondrial DNA and mitochondrial dysfunction in gastric cancer progression.
    Lee HC; Huang KH; Yeh TS; Chi CW
    World J Gastroenterol; 2014 Apr; 20(14):3950-9. PubMed ID: 24744584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deciphering the Spectrum of Mitochondrial DNA Mutations in Hepatocellular Carcinoma Using High-Throughput Sequencing.
    Yu C; Wang X; Huang L; Tong Y; Chen L; Wu H; Xia Q; Kong X
    Gene Expr; 2018 May; 18(2):125-134. PubMed ID: 29463347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NGS-based profiling reveals a critical contributing role of somatic D-loop mtDNA mutations in HBV-related hepatocarcinogenesis.
    Yin C; Li DY; Guo X; Cao HY; Chen YB; Zhou F; Ge NJ; Liu Y; Guo SS; Zhao Z; Yang HS; Xing JL
    Ann Oncol; 2019 Jun; 30(6):953-962. PubMed ID: 30887045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatic mutations in the D-loop and decrease in the copy number of mitochondrial DNA in human hepatocellular carcinoma.
    Lee HC; Li SH; Lin JC; Wu CC; Yeh DC; Wei YH
    Mutat Res; 2004 Mar; 547(1-2):71-8. PubMed ID: 15013701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic alterations in hepatocellular carcinoma: An update.
    Niu ZS; Niu XJ; Wang WH
    World J Gastroenterol; 2016 Nov; 22(41):9069-9095. PubMed ID: 27895396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-regional sequencing reveals intratumor heterogeneity and positive selection of somatic mtDNA mutations in hepatocellular carcinoma and colorectal cancer.
    Li X; Guo X; Li D; Du X; Yin C; Chen C; Fang W; Bian Z; Zhang J; Li B; Yang H; Xing J
    Int J Cancer; 2018 Sep; 143(5):1143-1152. PubMed ID: 29569724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial fission-induced mtDNA stress promotes tumor-associated macrophage infiltration and HCC progression.
    Bao D; Zhao J; Zhou X; Yang Q; Chen Y; Zhu J; Yuan P; Yang J; Qin T; Wan S; Xing J
    Oncogene; 2019 Jun; 38(25):5007-5020. PubMed ID: 30894684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of 5-methylcytosine and 5-hydroxymethylcytosine with mitochondrial DNA content and clinical and biochemical parameters in hepatocellular carcinoma.
    Shen F; Huang W; Qi JH; Yuan BF; Huang JT; Zhou X; Feng YQ; Liu YJ; Liu SM
    PLoS One; 2013; 8(10):e76967. PubMed ID: 24143196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Entropy of mitochondrial DNA circulating in blood is associated with hepatocellular carcinoma.
    Campo DS; Nayak V; Srinivasamoorthy G; Khudyakov Y
    BMC Med Genomics; 2019 Jun; 12(Suppl 4):74. PubMed ID: 31167647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Target genes discovery through copy number alteration analysis in human hepatocellular carcinoma.
    Gu DL; Chen YH; Shih JH; Lin CH; Jou YS; Chen CF
    World J Gastroenterol; 2013 Dec; 19(47):8873-9. PubMed ID: 24379610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial Metabolic Signatures in Hepatocellular Carcinoma.
    Lee HY; Nga HT; Tian J; Yi HS
    Cells; 2021 Jul; 10(8):. PubMed ID: 34440674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of mitochondrial DNA alterations in the serum of hepatocellular carcinoma patients.
    Okochi O; Hibi K; Uemura T; Inoue S; Takeda S; Kaneko T; Nakao A
    Clin Cancer Res; 2002 Sep; 8(9):2875-8. PubMed ID: 12231530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic structures of dysplastic nodule and concurrent hepatocellular carcinoma.
    Lee M; Kim K; Kim SY; Jung SH; Yoon J; Kim MS; Park HC; Jung ES; Chung YJ; Lee SH
    Hum Pathol; 2018 Nov; 81():37-46. PubMed ID: 29949741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial apurinic/apyrimidinic endonuclease 1 enhances mtDNA repair contributing to cell proliferation and mitochondrial integrity in early stages of hepatocellular carcinoma.
    Bazzani V; Barchiesi A; Radecka D; Pravisani R; Guadagno A; Di Loreto C; Baccarani U; Vascotto C
    BMC Cancer; 2020 Oct; 20(1):969. PubMed ID: 33028238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between copy number of mitochondrial DNA and clinico-pathologic parameters of hepatocellular carcinoma.
    Yamada S; Nomoto S; Fujii T; Kaneko T; Takeda S; Inoue S; Kanazumi N; Nakao A
    Eur J Surg Oncol; 2006 Apr; 32(3):303-7. PubMed ID: 16478656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NAFLD Related-HCC: The Relationship with Metabolic Disorders.
    Zhang X
    Adv Exp Med Biol; 2018; 1061():55-62. PubMed ID: 29956206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial fission forms a positive feedback loop with cytosolic calcium signaling pathway to promote autophagy in hepatocellular carcinoma cells.
    Huang Q; Cao H; Zhan L; Sun X; Wang G; Li J; Guo X; Ren T; Wang Z; Lyu Y; Liu B; An J; Xing J
    Cancer Lett; 2017 Sep; 403():108-118. PubMed ID: 28624623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TFAM depletion overcomes hepatocellular carcinoma resistance to doxorubicin and sorafenib through AMPK activation and mitochondrial dysfunction.
    Zhu Y; Xu J; Hu W; Wang F; Zhou Y; Xu W; Gong W; Shao L
    Gene; 2020 Aug; 753():144807. PubMed ID: 32461017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.